Pharmaceuticals 
This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 39.
CRF Health Becomes The First To Achieve Gold Standard
CRF Health, the developer of the TrialMax® Suite of electronic Clinical Outcome Assessment Solutions (eCOA) for the life sciences industry, becomes the first eCOA company to complete a full validation study for Professor Juniper’s ACQ and AQLQ questionnaires to the “Gold Standard” based on her recently released “Levels of Acceptability of Electronic Versions” rating system.
Source: Pharmaceutical Online News - February 5, 2013 Category: Pharmaceuticals Source Type: news
Sun Pharma gets USFDA nod for anti-cancer injection
Sun Pharmaceutical Industries today said it has received US health regulator's approval to market generic version of Doxil injection.
Source: The Economic Times Healthcare and Biotech News - February 5, 2013 Category: Pharmaceuticals Source Type: news
Lars Frederiksen steps down as CEO of Chr. Hansen Holding A/S; Cees de Jong is appointed new CEO
Company announcement no. 5/2013
After 33 years at Chr. Hansen, 14 years in Executive Management and eight years
as CEO, Lars Frederiksen has decided to step down as CEO of Chr. Hansen Holding
A/S as of 31 March 2013, in order to devote more time to non-executive Board
positions.
The Board of Directors has appointed Cees de Jong (51) as new CEO of Chr.
Hansen Holding A/S as of 1 April 2013.
Lars Frederiksen joined Chr. Hansen in 1980 and was appointed member of the
Executive Board of
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Kesko Board's proposals to the Annual General Meeting
KESKO CORPORATION STOCK EXCHANGE RELEASE 05.02.2013 AT 09.20 1(2)
Kesko Corporation's Board has decided to propose to the Annual General Meeting
to be convened for 8 April 2013 that the dividend payable for the year 2012 be
€1.20 per share, that the clause in Article 9 of the Articles of Association
concerning the delivery of the notice of a General Meeting be amended, that the
Board be authorised to acquire the company's own B shares and to issue own B
shares held by the company as treasury sh
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Keskon hallituksen ehdotukset varsinaiselle yhtiökokoukselle
KESKO OYJ PÖRSSITIEDOTE 05.02.2013 KLO 09.20 1(2)
Kesko Oyj:n hallitus on päättänyt ehdottaa 8.4.2013 kokoontuvalle varsinaiselle
yhtiökokoukselle vuodelta 2012 maksettavaksi osingoksi 1,20 euroa osakkeelta,
yhtiöjärjestyksen yhtiökokouksen koolle kutsumista koskevan määräyksen
muuttamista ja hallituksen valtuuttamista päättämään yhtiön omien B-osakkeiden
hankkimisesta ja yhtiön hallussa olevien omien B-osakkeiden antamisesta.
Hallituksen tarkastusvaliokunta ehdottaa, että yhtiön tilintarkastaj
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Osakkeenomistajien ehdotukset varsinaiselle yhtiökokoukselle
KESKO OYJ PÖRSSITIEDOTE 05.02.2013 KLO 09.25 1(1)
Kesko Oyj:n osakkeenomistajat, joilla on yhteensä yli 10 % yhtiön osakkeiden
tuottamasta äänimäärästä, ovat tehneet ehdotuksen 8.4.2013 pidettävälle
varsinaiselle yhtiökokoukselle hallituksen jäsenmäärästä, palkkioista ja kulujen
korvausperusteista.
Ehdotus hallituksen jäsenten lukumääräksi
Kesko Oyj:n osakkeenomistajat, joilla on yhteensä yli 10 % yhtiön osakkeiden
tuottamasta äänimäärästä, ovat ehdottaneet, että yhtiön varsinainen yhtiökokou
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Shareholders' proposals to the Annual General Meeting
KESKO CORPORATION STOCK EXCHANGE RELEASE 05.02.2013 AT 09.25 1(2)
Kesko Corporation's shareholders jointly representing over 10% of the votes
carried by the company shares have made a proposal to the Annual General Meeting
to be held on 8 April 2013 for the number of Board members, their remuneration
and the reimbursement of their expenses.
Proposal for the number of Board members
Kesko Corporation's shareholders jointly holding over 10% of the votes carried
by the company shares have propose
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
DGAP-AFR: Forst Ebnath Aktiengesellschaft: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act] with the objective of Europe-wide distribution
Forst Ebnath Aktiengesellschaft / Preliminary announcement on the disclosure
of financial statements
05.02.2013 08:24
Announcement according to articles 37v, 37w, 37x ff. WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Forst Ebnath Aktiengesellschaft hereby announces that the following
financial reports shall be disclosed :
Report: Inte
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Data on OMX Baltic Benchmark Fund issued shares as of February 04, 2013
OMX Baltic Benchmark Fund share price on February 04, 2013 – 7.3956 EUR
OMX Baltic Benchmark Fund number of shares issued on February 04, 2012 – 0 units
OMX Baltic Benchmark Fund number of shares redeemed on February 04, 2012 – 0
units
The total number of OMX Baltic Benchmark Fund shares admitted to trading as of
February 04, 2012 –341273units
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Öresunds substansvärde 1 – 31 januari 2013
· Substansvärdet[1] (http://connect.ne.cision.com#_ftn1) ökade med 5,9 procent
till 123 kronor per aktie
· Index[2] (http://connect.ne.cision.com#_ftn2) steg med 5,5 procent
SUBSTANSVÄRDETS FÖRDELNING DEN 31 JANUARI 2013
Värdepapper Antal Marknads Kr/akt Andel,
-värde, ie %
Mkr
Noterade värdepapper
Bilia
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Substansvärde per 2013-01-31
Substansvärdet ökade med 8 procent till 142 kr per aktie.
Per 31 januari 2013, uppgick Creades substansvärde till 142 kr per aktie. Detta
innebär en ökning med 8 procent[1] (http://#_ftn1) sedan årsskiftet, då
substansvärdet uppgick till 132 kr per aktie.
Substansvärdets fördelning finns i tabellen i bifogad PDF.
Stockholm den 5 februari 2013
Stefan Charette, verkställande direktör, telefon 08 – 412 011 00.
Creades är listat på First North med Handelsbanken Capital Markets som Certified
Advi
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Notice of Extraordinary General Meeting of Anoto Group AB (publ.)
LUND, February 5, 2013 - The shareholders of Anoto Group AB (publ.), reg. no
556532-3929, hereinafter “Anoto Group” or the “Company”, are invited to attend
the Extraordinary General Meeting to be held at 1.00 p.m. on Monday 4 March
2013 at the Company’s premises at Traktorvägen 11, Lund, Sweden.
Notification of participation in the Extraordinary General Meeting
etc.Shareholders wishing to attend the Extraordinary General Meeting must be
entered as shareholders in the share register maintaine
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
MOBERG DERMA YEAR-END REPORT 2012
DOUBLED REVENUE, PROFITABLE AND ESTABLISHMENT IN THE U.S.
FULL-YEAR (JAN-DEC 2012)
· Revenue MSEK 112.5 (55.9)
· Operating profit MSEK 12.6 (-7.6), MSEK 19.2 excluding acquisition-related
costs
· Net profit after tax MSEK 35.8 (-6.4), MSEK 42.4 excluding acquisition
-related costs
· Earnings per share SEK 3.68 (-0.82)
· Operating cash flow per share SEK 0.97 (-0.99)
· The Board proposes no dividend for the 2012 fiscal year
FOURTH QUARTER (OCT-DEC 2012)
· Revenue MSEK 30.2 (20.5)
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
MOBERG DERMA BOKS.SKOMMUNIKÉ 2012
FÖRDUBBLAD OMSÄTTNING, POSITIVT RESULTAT OCH ETABLERING I USA
HELÅRET (JAN-DEC 2012)
· Nettoomsättning 112,5 MSEK (55,9)
· Rörelseresultat 12,6 MSEK (-7,6), 19,2 MSEK exklusive förvärvsrelaterade
kostnader
· Resultat efter skatt 35,8 MSEK (-6,4), 42,4 MSEK rensat för
förvärvsrelaterade kostnader
· Resultat per aktie efter utspädning 3,68 SEK (-0,82)
· Operativt kassaflöde per aktie 0,97 SEK (-0,99)
· Styrelsen föreslår att ingen utdelning lämnas för räkenskapsåret 2012
FJÄRDE KVART
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Invitation to the Annual General Meeting
Neste Oil Corporation
Stock Exchange Release
5 February 2013 at 9.30 a.m. (EET)
Invitation to the Annual General Meeting
Neste Oil Corporation's shareholders are hereby invited to the Annual General
Meeting to be held on Thursday, 4 April 2013, beginning at 11.00 am EET, at
Finlandia Hall at Mannerheimintie 13 e, 00100 Helsinki. Registration and the
distribution of voting papers will begin at 10.00 am EET.
A. Matters to be discussed and the agenda
The following matters will be discussed and
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Kesko's share-based compensation plan in 2013 and compensation in 2012
KESKO CORPORATION STOCK EXCHANGE RELEASE 05.02.2013 AT 09.30 1(2)
Kesko Corporation's Board has decided the target group for the 2013 vesting
period under Kesko's three-year share-based compensation plan to consist of some
150 Kesko management employees and other named key persons, the vesting criteria
for the vesting period, and the maximum share award amount of each target group
member. At the same time, the Board decided to grant a total of 66,276 own B
shares held as treasury shares by the
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Kutsu varsinaiseen yhtiökokoukseen
Neste Oil Oyj
Pörssitiedote
5.2.2013 klo 9.30
Kutsu varsinaiseen yhtiökokoukseen
Neste Oil Oyj:n osakkeenomistajat kutsutaan varsinaiseen yhtiökokoukseen, joka
pidetään torstaina 4.4.2013 kello 11.00 alkaen Finlandia-talolla (Finlandia-
sali) osoitteessa Mannerheimintie 13 e, 00100 Helsinki. Kokoukseen
ilmoittautuneiden vastaanottaminen ja äänestyslippujen jakaminen aloitetaan
kello 10.00.
A. Yhtiökokouksessa käsiteltävät asiat ja niiden käsittelyjärjestys
Yhtiökokouksessa käsitellään seu
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Keskon osakepalkkiojärjestelmä vuonna 2013 ja vuoden 2012 toteuma
KESKO OYJ PÖRSSITIEDOTE 05.02.2013 KLO 09.30 1(2)
Kesko Oyj:n hallitus on päättänyt Keskon kolmivuotisen osakepalkkiojärjestelmän
ansaintajakson 2013 kohderyhmäksi n. 150 Keskon johtoon kuuluvaa ja nimettyä
muuta avainhenkilöä, ansaintajakson ansaintakriteerit ja kunkin kohderyhmään
kuuluvan osakepalkkion enimmäismäärän. Samalla hallitus päätti antaa
osakepalkkiojärjestelmän ansaintajakson 2012 ansaintakriteerien täyttymisen
perusteella yhteensä 66.276 yhtiön hallussa olevaa omaa B-osaketta.
O
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Vacon Oyj:n tilinpäätöstiedote 1.1. - 31.12.2012
Vacon Oyj, Pörssitiedote, 5.2.2013 kello 9.30
Vacon julkistaa tällä pörssitiedotteella tilinpäätökseen sisältyvät arvopaperin
arvoon olennaisesti vaikuttavat tiedot. Tilinpäätöstiedote kokonaisuudessaan on
tämän tiedotteen liitteenä sekä ladattavissa yhtiön www-sivuilla osoitteessa
www.vacon.fi suomeksi ja osoitteessa www.vacon.com englanniksi.
Loka-joulukuun pääkohdat:
* Saadut tilaukset olivat 94,4 miljoonaa euroa (76,9 milj. euroa). Kasvua
edellisen vuoden vastaavasta ajankohdasta ol
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Vacon Plc Financial Statement Bulletin 1 January - 31 December 2012
Vacon Plc, Stock Exchange Release, 5 February 2013 at 9.30 pm (EET)
In this stock exchange release Vacon is publishing information that has a
significant impact on securities included in the financial statements. The full
financial statements are in the appendix to this release and can be downloaded
from the company's website in English at www.vacon.com and in Finnish at
www.vacon.fi.
October-December summary:
* Order intake totalled MEUR 94.4 (MEUR 76.9), an increase of 22.8 % from the
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
BOLAGSSTÄMMOKALLELSE
Norvestia Abp Kallelse till årsstämma 5.2.2013 kl. 9.30
BOLAGSSTÄMMOKALLELSE
Aktieägarna i Norvestia Abp kallas till ordinarie bolagsstämma som hålls
tisdagen den 19 mars 2013 kl. 13.00 i Börssalen, Fabiansgatan 14, 00100
Helsingfors. Emottagandet av personer som har anmält sig till stämman och
utdelning av röstsedlar börjar kl. 12.00.
A. ÄRENDEN SOM BEHANDLAS PÅ BOLAGSSTÄMMAN
På bolagsstämman behandlas följande ärenden:
1. Öppnande av stämman
2. Konstit
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
Interim report for Q1 2012/13 (1 October to 31 December 2012)
-- Revenue for Q1 2012/13 totalled DKK 268.8m against DKK 234.4m in Q1
2011/12, corresponding to an increase of 15% and organic growth of 8%. In
local currencies, growth totalled 13%.
-- The gross margin in Q1 was 52.1% against 56.7% for the prior-year period.
As expected, the reduced gross margin is explained by the channel and
customer mix, lower earnings on the acquired electrode business and
increased distributor sales in connection with a single large EMS
Source: Medical News (via PRIMEZONE) - February 5, 2013 Category: Pharmaceuticals Source Type: news
2.3 Million Triaminic and Theraflu Products Recalled after Children...
More than two million cold and flu medications are being recalled after it was reported that several children opened the child-resistant caps that did not work properly. A Jan. 31 ABC news report...(PRWeb February 03, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10390803.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
NSG’s Photometric Accuracy Calibration Standards for UV/VIS...
NSG Precision has an elite line of...(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10366295.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
Leading Phoenix Pain Management Clinic, Arizona Pain Specialists, Now...
Arizona Pain Specialists, the leading pain management providers in the Phoenix AZ area, have developed an integrated approach to helping patients effectively deal with pain. The Award Winning pain...(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/painmanagementphoenix/arizonapainspecialists/prweb10393143.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
Krisam Group and Global Events Partners Announce New National Sales...
Colleen Brzozowski brings strong ties to the financial and insurance market to the Krisam Group and Global Events Partners Chicago Office(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10391703.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces...
Diet Doc recently released refined coconut oil known as MCT oil, known to begin burning fat in as little as 30 minutes after consumption.(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/coconut-oil/fast-weight-loss/prweb10390549.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
New Resource for Ophthalmology Clinical Trials: Strategic Alliance...
Research Dynamics Consulting Group, a full service Contract Research Organization (CRO), and ClinROC, LLC, a consulting company of Ophthalmology experts, are announcing a strategic alliance to provide...(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/clinroc/clinicaltrial/prweb10388178.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
d’Oliveira & Associates Provides New Up to Date Information to...
d’Oliveira & Associates has added three subpages to its NuvaRing webpage.(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10388092.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
Lupin Pharmaceuticals Begins Nationwide Rollout of POP’s iPoint Mobile...
Pharmaceutical Operations Provider (POP) announced today that Lupin Pharmaceuticals of Baltimore, MD has begun deploying iPoint Mobile for iPad. All 160 sales representatives are upgrading to iPads...(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10386862.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
NH IT Staffing Firm Digital Prospectors Corp Uses Facebook to Help...
By encouraging Likes, shares and donations through it's brand Facebook Page, DPC helps spread the word and raise funds for hurricane victims with a month-long campaign.(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10384107.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
Soltex Consulting Certified as a Woman Business Enterprise
Soltex Consulting is proud to announce it has been certified as a Woman Business Enterprise. Soltex is a boutique firm providing eClinical consulting - process re-engineering, change management, and...(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/Soltex/wbe/prweb10370175.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
Human Research Protection and Understanding the Landscape of AAHRPP...
Xtalks presents a live webinar on Wednesday, February 20, 2013, 2:00pm EST. Dr. Marjorie Speers, President and CEO, AAHRPP, will discuss the AAHRPP accreditation process and benefits of accreditation.(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10359324.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
ACTCM Will Be Celebrating Chinese New Year with a Day of Fun and...
The American College of Traditional Chinese Medicine has organized a fun-filled day of events on February 10, 2013 to celebrate the Chinese New Year.(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/traditional-chinese-medic/san-francisco/prweb10355816.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
DePuy Pinnacle Hip Lawsuits: Bernstein Liebhard LLP Notes Discovery...
The Firm is actively filing lawsuits in the federal DePuy Pinnacle litigation underway in Texas.(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/depuy-pinnacle-lawsuits/depuy-pinnacle-litigation/prweb10394788.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
DePuy ASR Hip Lawsuit News: Expert Testifies on Toxicity of Metal...
An expert witness in the first DePuy ASR hip lawsuit to go to trial has testified that the Plaintiff’s metal-on-metal hip failed because of toxic metal debris shed from the device.(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/depuy-asr-hip-lawsuits/depuy-asr-litigation/prweb10394696.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
Global Piracy and Counterfeiting Consultants Warns US Citizens About...
The Global Piracy and Counterfeiting Consultants is warning all US citizens, and for that matter citizens around the world to not take the path of least resistance, and purchase any type of drug on...(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10392783.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
Infinata’s BioPharm Insight™ Achieves Record Growth in 2012
Secures position as thought leader in the healthcare community through educational webinars, new product enhancements and forward-looking journalism.(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10389792.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
ERT, Johns Hopkins University and the University of Washington Expand...
Home Monitoring May Improve Quality of Life for CF Patients and Reduce Healthcare Costs(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10388304.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
US Drug Watchdog Now Urges Diabetics Who Used the Diabetes Drug Actos...
The US Drug Watchdog now fears that most diabetics who took the diabetes drug called Actos, and then developed bladder cancer would never consider the possibility that the bladder cancer, and this...(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10386430.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
Biogen Idec to Speak at Pharmica Consulting’s Risk-based Monitoring...
Pharmica Consulting, the life sciences industry leader in cutting edge processes and technology, is pleased to announce that Najma Saleem from Biogen Idec will be speaking at Pharmica’s Risk-based...(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10378879.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
Secretary of Department of Environmental Protection, Michael Krancer,...
The Pittcon 2013 Organizing Committee is pleased to announce that the Secretary of the Department of Environmental Protection, Michael Krancer, will facilitate the Conferee Networking Session, “The...(PRWeb February 04, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10345596.htm
Source: PRWeb: Medical Pharmaceuticals - February 5, 2013 Category: Pharmaceuticals Source Type: news
Hospitals taking old-fashioned house call route to help stem medical costs, admissions
A growing number of health systems, including some in Arizona, are sending teams of doctors, nurses and physician assistants into homes — much like the traditional house calls of yesteryear — to help cut costs and hospital stays. For the full story, click on The Wall Street Journal link below.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 5, 2013 Category: Pharmaceuticals Source Type: research
GSK increases stake in its publicly-listed Consumer Healthcare subsidiary in India to 72.5 per cent
GlaxoSmithKline plc (LSE: GSK) announced today that, pursuant to the voluntary open offer undertaken by its subsidiary, GlaxoSmithKline Pte. Ltd, GSK has successfully increased its stake in GlaxoSmithKline Consumer Healthcare Ltd, its publicly-listed Consumer Healthcare subsidiary in India, from 43.2% to 72.5%
Source: GSK news - February 5, 2013 Category: Pharmaceuticals Source Type: news
LEVOCETIRIZINE DIHYDROCHLORIDEtablet, Film Coated [Sun Pharma Global FZE]
Updated Date: Feb 5, 2013 EST
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 5, 2013 Category: Drugs & Pharmacology Source Type: news
WSJ: Did political pressure, fiscal gimmicks force AZ Gov. Jan Brewer’s hand?
Calling it a “spectacular flip-flop,” The Wall Street Journal takes a closer look at why Arizona Gov. Jan Brewer changed her tune on Medicaid expansion.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 4, 2013 Category: Pharmaceuticals Source Type: research
Sharp Increase In FDA Drug Approvals A Major Factor In Biotech Industry's Success
A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012.
Source: Pharmaceutical Online News - February 4, 2013 Category: Pharmaceuticals Source Type: news
FDA Approval Of Generic Version Of Cancer Drug Doxil Is Expected To Help Resolve Shortage
The U.S. Food and Drug Administration today approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection).
Source: Pharmaceutical Online News - February 4, 2013 Category: Pharmaceuticals Source Type: news
PCI Sponsors Second Annual Massachusetts CRO/CMO Symposium
PCI (www.pcisynthesis.com), a 13-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced its major sponsorship of the second annual Massachusetts CRO/CMO Symposium.
Source: Pharmaceutical Online News - February 4, 2013 Category: Pharmaceuticals Source Type: news
Development of TB Vaccine Hits Snag
Efforts to develop the first new tuberculosis vaccine in 90 years stumbled when the most advanced vaccine in testing failed to protect infants in a clinical study.
Source: WSJ.com: Health - February 4, 2013 Category: Pharmaceuticals Tags: FREEEUROPE Source Type: news
